InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (15 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
15
T+90 hit rate
0%
T+90 mean return
-0.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by LaPlume Joseph W, Vice-Président Exécutif. Officer active across 2 companies, notably Charles River Laboratories International, INC.. Cumulatively, 46 disclosures have been logged. Split: 1 buy · 15 sells. Total volume traded: €3.2m. History available since 28 May 2021. The latest transaction was filed on 10 August 2026 (Don). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to LaPlume Joseph W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations46 total
257 shares0Common StockSEC:0001100682-26-000128:0
5,257 shares@ US$180.710.011% mcap12.5% of flowCommon StockSEC:0001100682-26-000097:0
744 shares@ US$180.710.0016% mcap1.8% of flowCommon StockSEC:0001100682-26-000097:1
235 shares@ US$180.710.0005% mcap0.6% of flowCommon StockSEC:0001100682-26-000097:2
243 shares@ US$160.300.0005% mcap0.5% of flowCommon StockSEC:0001100682-26-000075:0
185 shares@ US$156.730.0003% mcap0.4% of flowCommon StockSEC:0001100682-26-000075:1
25 shares@ US$174.540.1% of flowCommon StockSEC:0001100682-26-000024:0
Canonical exit: 1 Jun 2026 (T+90)
5,456 shares0Common StockSEC:0001100682-26-000016:0
400 shares@ US$163.720.8% of flowCommon StockSEC:0001100682-26-000002:0
800 shares@ US$157.601.5% of flowCommon StockSEC:0001100682-25-000036:0
400 shares@ US$150.040.7% of flowCommon StockSEC:0001127602-25-020282:0
385 shares0Common StockSEC:0001127602-25-017074:0
6,709 shares@ US$135.6311.7% of flowCommon StockSEC:0001127602-25-016553:0
161 shares@ US$136.730.3% of flowCommon StockSEC:0001127602-25-015900:0
122 shares@ US$136.730.2% of flowCommon StockSEC:0001127602-25-015900:1
83 shares@ US$138.650.1% of flowCommon StockSEC:0001127602-25-015900:2
500 shares@ US$145.411.0% of flowCommon StockSEC:0001127602-25-014484:0
4,400 shares@ US$162.5010.5% of flowCommon StockSEC:0001127602-25-006249:0
2,738 shares0Common StockSEC:0001127602-25-002780:0
1,780 shares@ US$199.365.0% of flowCommon StockSEC:0001127602-24-022003:0
311 shares0Common StockSEC:0001127602-24-017714:0
2,111 shares0Common StockSEC:0001127602-24-017309:0
223 shares@ US$214.510.7% of flowCommon StockSEC:0001127602-24-017116:0
243 shares@ US$217.210.7% of flowCommon StockSEC:0001127602-24-016726:0
1,304 shares@ US$226.974.2% of flowCommon StockSEC:0001127602-24-015276:0
25 of 46 declarations
About LaPlume Joseph W
LaPlume Joseph W is Executive Vice President and appears in 45 filings in total. Across the 45 sampled recent filings, the aggregated amounts are EUR 3,730 for buys and EUR 3,167,277 for sells, with the modal transaction nature listed as Cession, for Charles River Laboratories International, INC. (XNAS), where he is also identified as EVP, Corp Strategy & Develop. The sampled filings span from 2021-06-01 to 2026-06-02.
